Rifaximin: irritable bowel syndrome

Area of Science:

• Pharmacy
• Pharmacology
• Drug Utilization

Background:

• Off-label drug use is common in clinical practice.
• Information on unapproved drug uses is often fragmented.
• Practitioners need reliable resources to assess off-label drug safety and efficacy.

Purpose of the Study:

• To introduce a resource for off-label drug information.
• To assist healthcare professionals in identifying relevant literature on unapproved drug uses.
• To support evidence-based decision-making for off-label drug prescriptions.

Main Methods:

• Extraction of content from the "Off-Label Drug Facts" publication.
• Compilation of literature references for specific off-label drug uses.
• Focus on practitioner-oriented information for clinical application.

Main Results:

• Provides a structured approach to accessing off-label drug literature.
• Enables quick identification of published studies on unapproved drug indications.
• Facilitates the assessment of the rationality of specific off-label drug uses.

Conclusions:

• "Off-Label Drug Facts" serves as a valuable tool for clinicians.
• The resource supports informed patient care decisions regarding unapproved drug uses.
• It bridges the gap between available literature and clinical application of off-label medications.